Prednisone and Hypersensitivity - a phase IV clinical study of FDA data
Summary:
Hypersensitivity is found among people who take Prednisone, especially for people who are female, 40-49 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Prednisone and have Hypersensitivity. It is created by eHealthMe based on reports of 523,651 people who have side effects when taking Prednisone from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
523,651 people reported to have side effects when taking Prednisone.
Among them, 12,636 people (2.41%) have Hypersensitivity.
What is Prednisone?
Prednisone has active ingredients of prednisone. It is often used in rheumatoid arthritis. eHealthMe is studying from 531,346 Prednisone users for its effectiveness, alternative drugs and more.
What is Hypersensitivity?
Hypersensitivity is found to be associated with 3,301 drugs and 2,861 conditions by eHealthMe.
Number of Prednisone and Hypersensitivity reports submitted per year:
Time on Prednisone when people have Hypersensitivity *:
Gender of people who have Hypersensitivity when taking Prednisone*:
Age of people who have Hypersensitivity when taking Prednisone *:
Common drugs people take besides Prednisone *:
Common side effects people have besides Hypersensitivity *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Prednisone and have Hypersensitivity?
Check whether Hypersensitivity is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Hypersensitivity and when was it recovered:
Expand to all the drugs that have ingredients of prednisone:
- Hypersensitivity and drugs with ingredients of prednisone (3,186 reports)
Alternative drugs to, pros and cons of Prednisone:
- Prednisone (531,346 reports)
Common Prednisone side effects:
- Drug ineffective: 66,683 reports
- Fatigue (feeling of tiredness): 46,071 reports
- Pain: 44,380 reports
- Breathing difficulty: 39,929 reports
- Joint pain: 38,003 reports
- Diarrhea: 32,985 reports
- Rashes (redness): 31,608 reports
Browse all side effects of Prednisone:
a b c d e f g h i j k l m n o p q r s t u v w x y zHypersensitivity treatments and more:
- Hypersensitivity (238,045 reports)
COVID vaccines that are related to Hypersensitivity:
- Hypersensitivity in Moderna COVID Vaccine
- Hypersensitivity in Pfizer BioNTech Covid Vaccine
- Hypersensitivity in Johnson and Johnson Covid Vaccine
Common drugs associated with Hypersensitivity:
- Enbrel: 13,291 reports
- Methotrexate: 12,945 reports
- Prednisone: 12,636 reports
- Humira: 11,185 reports
- Orencia: 8,175 reports
- Actemra: 8,085 reports
- Adapalene: 7,698 reports
- Remicade: 7,695 reports
- Arava: 6,319 reports
- Cimzia: 6,285 reports
All the drugs that are associated with Hypersensitivity:
- Hypersensitivity (3,301 drugs)
Common conditions associated with Hypersensitivity:
- Rheumatoid arthritis: 17,389 reports
- Multiple sclerosis: 8,176 reports
- Asthma: 6,520 reports
- High blood pressure: 5,656 reports
- Psoriasis: 4,121 reports
- Pain: 3,964 reports
- Acne: 3,557 reports
All the conditions that are associated with Hypersensitivity:
- Hypersensitivity (2,861 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on prednisone (the active ingredients of Prednisone) and Prednisone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Pantosin and Aggression - 8 seconds ago
- Armour Thyroid and Fludeoxyglucose F 18 drug interaction - 14 seconds ago
- Xopenex and Dermatitis Diaper - 16 seconds ago
- Prochlorperazine Edisylate and Subdural Haematoma - 18 seconds ago
- Unithroid and Blood Iron Decreased - 18 seconds ago
- Welchol and Spinal Cord Compression - 20 seconds ago
- Dysfunctional Uterine Bleeding (Dub) and Upper-Airway Cough Syndrome - 20 seconds ago
- Darvocet and Ocular Hypertension - 22 seconds ago
- Tranxene and Cystitis Aggravated - 24 seconds ago
- Combipatch and Malignant Neoplasm Progression - 28 seconds ago